Navigation Links
Biosensors Receives CE Mark Approval for Its BioMatrix(R) Drug-Eluting Coronary Stent System
Date:1/17/2008

SINGAPORE, Jan. 18 /PRNewswire/ -- International Group, Ltd. (Bloomberg: BIG SP, Company or Biosensors), today announced that the Company has received Conformite Europeenne (CE) Mark approval for its BioMatrix(R) drug-eluting stent system, enabling commercialization of this product in the European Union and the countries in Asia and Latin America that recognize the CE Mark. The BioMatrix drug-eluting stent system, developed internally by the Company, consists of a unique drug-eluting stent that incorporates a biodegradable polymer and the Company's proprietary drug, Biolimus A9(R), which inhibits restenosis, or re-narrowing of the arteries, following stent implantation.

Terumo Corporation (Terumo), a licensee of Biosensors' BioMatrix technology, also announced CE Mark approval for its NOBORI(TM) drug-eluting stent system. In October 2003, Biosensors and Terumo entered into a licensing agreement that granted Terumo the rights to sell the NOBORI drug-eluting stent system exclusively in Japan and non-exclusively in countries outside Japan excluding the United States. Under this agreement, Terumo will share a portion of the revenues from the sales of NOBORI with Biosensors. In May 2007, Terumo commenced the clinical trial of the NOBORI drug-eluting stent system required for Japanese regulatory approvals.

"We are very pleased to have received CE Mark approval for our BioMatrix stent and will immediately implement our strategy to make this product available in the approved markets. Our growth potential in these markets is very strong, as BioMatrix and NOBORI will be the only drug-eluting stents currently available which incorporate a biodegradable polymer coating together with an immunosuppressive drug. Positive clinical data position the BioMatrix stent system to be a potential break-through product for patients and physicians," stated Mr. Yoh-Chie Lu, Chairman and Chief Executive Officer.

Professor Eberhard Grube, Chief of Angiology and Cardi
'/>"/>

SOURCE Biosensors International Group, Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Model is first to compare performance of biosensors
2. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
3. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
4. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
5. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
6. IsoTis Receives FDA Clearance for Accell Family of Products
7. Actavis Receives Approval of Fentanyl Transdermal System in the U.S.
8. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
9. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
10. XTL Receives Staff Letter From NASDAQ
11. XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014  An entire month ... of inherited neuropathies – Charcot-Marie-Tooth disease (CMT) – a ... legs, causing extreme muscle atrophy, weakness, and foot and ... US and millions worldwide. CMT is a progressive disease, ... their legs, requiring mobility devices such as leg braces, ...
(Date:9/19/2014)... Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage ... difficult to manufacture proteins including biosimilar therapeutics, today announced ... Annual NewsMakers in the Biotech Industry conference in ... , chief executive officer of Pfenex, will provide an ... on Friday, September 26, 2014 at 10:00 a.m. EDT/7:00 ...
(Date:9/19/2014)... 19, 2014 Cereal grain scientists, ... will gather October 5–8, 2014, for the AACC ... Convention Center in Providence, Rhode Island. The comprehensive ... of food scientists, chemists, microbiologists, nutritionists, and those ... production management. To date, 1,000 attendees have registered ...
(Date:9/19/2014)... LONDON , September 19, 2014 ... Spain , available today on PharmaBoardroom.com ... of the Eurozone crisis that rocked the Spanish economy in ... the Spanish pharma community has remained pragmatic in times of ... is still the fifth biggest European market, and the ...
Breaking Biology Technology:September is Charcot-Marie-Tooth (CMT) Awareness Month - Scheduled events, activities and important partnerships announced throughout the month! 2Pfenex to Present at Upcoming Industry Conference on September 26 2Latest Research on Cereal Grain Quality, Health Benefits and Food Production to be Presented During the AACC International Annual Meeting 2Latest Research on Cereal Grain Quality, Health Benefits and Food Production to be Presented During the AACC International Annual Meeting 3PharmaBoardroom Releases New Spain Pharmaceuticals Report 2PharmaBoardroom Releases New Spain Pharmaceuticals Report 3
... Oct. 8 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.,("Oncolytics") ... completed initial scale up of its manufacturing ... scale up of primary production and downstream ... Council Biotechnology,Research Institute (NRC-BRI) located in Montreal, ...
... Matrox Graphics Inc., the leading,manufacturer of specialized graphics ... Xenia(TM) Series display controller boards with its,ME/CCL medical ... native PCI Express single-slot board with,all-digital, triple-monitor output ... Xenia Series supports resolutions from <1MP to,8MP with ...
... a six-year battle with heart disease that included numerous medications, trips to ... found himself in the Intensive Care Unit at an Ohio hospital. Both ... of a transplant. , ... TUCSON, Ariz. (Business Wire EON) October ...
Cached Biology Technology:Oncolytics Biotech Inc. Completes Initial Scale Up of Manufacturing Process for REOLYSIN(R) to Commercial Scale 2Totoku Europe Chooses Matrox Xenia(TM) Series to Drive Medical Monitors 2 "Put Down the BBQ Ribs, We've Found You a Donor Heart," Nurse Tells Patient : Ohio Father near Death Gets Second Chance at Life with CardioWest&#8482; temporary Total Artificial Heart 2
(Date:9/19/2014)... which over thousands of years has adapted to the arctic ... makes the cold dangerous for you. , This is happening ... the cold provoking substance, called nonylphenol, comes from the use ... of being a endocrine disruptor, but when entering the worm ... to protect the cells in its body from cold damage. ...
(Date:9/18/2014)... deep in the primitive brainstem has revealed how we ... School of Medicine and the University at Buffalo School ... second "sleep node" identified in the mammalian brain whose ... produce deep sleep. , Published online in August in ... half of all of the brain,s sleep-promoting activity originates ...
(Date:9/18/2014)... "frequent flyers" program, fruit flies surely would be eligible ... increasing numbers of fruit fly research studies. One fruit ... and another is scheduled launch to the station Sept. ... December. , Fruit flies are biomedical research models studied ... organisms can reveal the basis for health and disease ...
Breaking Biology News(10 mins):Environmental pollutants make worms susceptible to cold 2Environmental pollutants make worms susceptible to cold 3No sedative necessary: Scientists discover new 'sleep node' in the brain 2Buzzing with activity: Fruit flies orbit Earth for science 2Buzzing with activity: Fruit flies orbit Earth for science 3Buzzing with activity: Fruit flies orbit Earth for science 4
... that shows clear evidence of evolution from lower primates ... well have depended in part on hyperactivation of the ... regulating perception, behavior and memory. , They reported that, ... in a regulatory segment of the prodynorphin gene, which ...
... BioSciences, Inc. today announced that data from its ... were presented at the 45th Annual Interscience Conference ... DC. The study represents the first demonstration ... infection by treatment with Sangamo's proprietary zinc finger ...
... ever wondered how the myriad insect forms—beetles, flies, dragonflies, ... Insects make up 75% of all species known. The ... of a combination of one or more factors: a ... an ability to adapt to new environments and exploit ...
Cached Biology News:Key brain regulatory gene shows evolution in humans 2Key brain regulatory gene shows evolution in humans 3Key brain regulatory gene shows evolution in humans 4Sangamo BioSciences demonstrates its ZFP treatment protects cells from HIV infection 2Islands in the Genome Promote Speciation 2
... set the standard for centrifugal concentration and drying. ... of centrifugal force, heat and vacuum to dry ... equipped with:, , TEFLON-coated Rotor Chamber ... , Three Selectable Heating Levels ...
... MB (for aqueous, other low volatility and ... respond to specific applications of molecular biology ... of heat-labile samples. The RC systems can ... traps and a wide selection of rotors ...
... vacuum concentrators/centrifugal evaporators offers a wide range ... and safe concentration of heat-labile samples. The ... or high vacuum pumps, a choice of ... rotors (eliminating sample loss by transfer), ensuring ...
... Jouan RC Standard MB (For small quantities ... biology samples) of vacuum concentrator/centrifugal evaporator systems ... and biochemistry for rapid and safe concentration ... be expanded with pumps, different of cold ...
Biology Products: